When the indication is reported as Cellular therapy (non-HCT) for the patient’s first event, or a post-HCT cellular therapy is reported on an HCT follow-up form, the Cellular Therapy Pre-CTED Form 4000 will come due. Once completed and the data is processed, FormsNet3℠ will add additional forms based on whether the product was genetically modified and if the infusion was post-HCT.

The following sub-sections are available for Cellular Therapy:

  • Cell Therapy Training Resources
  • CIBMTR Guidance Document for Reporting Autologous Cellular Therapies
  • Cell Therapy Reporting Preferences
  • How forms come due
    • Cell therapy, stand-alone (no HCT forms)
    • Co-infusion (with HCT)
    • Post-HCT Cellular Therapy (not genetically modified)
    • Combined follow up scenarios (HCT + CT (genetically modified))
      • HCT -> CT
      • CT -> HCT
      • 3+ events
  • Cell Therapy Studies
  • Common questions (to reduce the number of tickets)/Best practices
Last modified: May 25, 2022